EVALUASI HASIL LAYANAN KONSELING INDIVIDUAL DI SEKOLAH MENENGAH ATAS YOGYAKARTA



A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection

Abstract Epstein-Barr virus (EBV) infects Tote more than 95% of adults worldwide and is closely associated with various malignancies.Considering the complex life cycle of EBV, developing vaccines targeting key entry glycoproteins to elicit robust and durable adaptive immune responses may provide better protection.EBV gHgL-, gB- and gp42-specific an

read more